News About: Pharm. Industry
Dong-A Pharm launches liquid-type human growth hormone grotropin-II injectionDong-A Pharm announced it has launched a liquid-type human growth hormone grotropin-II injection based on the EP standards for the first time in Korea after successful developme...
|
Yungjin Pharm to mull pain-in capital increase of 20 billion won
Yungjin Pharm unveiled a plan to lure domestic investors via its pain-in capital increase of 20 billion won by designating the third party on March 2004.
To that end, the company will hold its special shareholders...
Pharmaceutical industry skeptical of large corporations' advancement into pharmacy market
Although some large companies have recently renewed their keen interest in entering domestic pharmacy market, the existing pharmacy chain firms including drug makers are skeptical of their success albeit growing conce...
Green Cross to start vaccine plant construction in Vietnam.
Green Cross Vaccine Inc. (President: Cornellis Monern) took a ground digging ceremony for the construction of a vaccine plant affiliated to the National Institute of Hygiene & Epidemiology(NIHE) of Vietnam in presenc...
Description for individual tablet identification to enforce from 2005.
For the prevention of any possible misuse of drugs, the KFDA is considering to adopt a provision of which an individual unit of oral solid formed drugs should be marked with an identification description taking effect...
Hanmi is set to establish its returned goods management center
Hanmi Pharm said on December 4 that it would set up a new grievance center to effectively deal with the excessive drug inventories at pharmacy upon request, including drugs whose shelf life was/will be expired.
The...
CJ to introduce FSAD treatment Femprox
CJ announced it entered into an exclusive distribution agreement with the U.S.-based NexMed Inc. on November 21 for the introduction of Femprox, which is effective in treating female sexual arousal disorder (FSAD).
...
Lilly Korea is willingness to compensate wholesalers over pricing reduction portion of Zyprexa...
Lilly Korea is willingness to compensate wholesalers over pricing reduction portion of Zyprexa tablet
Lilly Korea said on December 2 that it is willing to fully compensate the pricing reduction portion of domestic ...
Novartis Korea named Peter Maag as new president
Novartis Korea announced recently the appointment of Dr. Peter Maag as a new president and Dr. Frank Bobe, who was a former president for the Korean unit for three and half years, has become vice president of Novartis...
Company value to maximize with brand image.
"Brand is a competitiveness" becomes an axiom in the business arena these days, which seems to be quite true in the pharmaceutical companies. In the recent commercial advertising contest, quite a number of drug advert...